
Drug Coated PTA Balloon Catheter
Supplier Details
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Free Member (2022)
[ Hangzhou, ZH,China ]
Business Type: Manufacturer
Supplier has 5 products
Quick Details
Product Description
OVERVIEW
Drug Coated PTA Balloon Catheter
ENSURE EFFECTIVE DRUG DELIVERY OF A SAFE THERAPEUTIC DOSAGE
The Drug-Coated PTA Balloon Catheter, a versatile and effective PAD treatment option, features unique Coating Technology and is available on the 0.014”, 0.018” and 0.035” balloon catheter platforms.
Product Features
Drug Coated Paclitaxel Balloon Catheter
A carrrier or an excipient is not always necessary
Coating Technology
01
The DCB drug dose of paclitaxel is 3?g/mm².
02
UltraFree™ Coating Technology effectively controls paclitaxel crystallization process, resulting in a uniform and stable microcrystal drug coating.
02
03
Particle size distribution test results show that 75% of the particles related are in 5-10?m range.
03
04
The integrated UltraFree™ coating prevents the early drug flaking during the procedure preparation and the device tracking.
04
05
UltraFree™ Coating quickly disintegrates into microcrystalline particles at the lesion site and allows rapid drug transfer to the arterial wall.
06
The effective drug tissue concentration at the lesion site lasts for more than 90 days.
06
More options with the clinically proven platforms
The DCB is based upon the PTA balloon platform and features
Low entry profile and excellent crossability
Advanced pushability
Long balloon lengths up to 220mm
ORDER INFORMATION
ZENFLuxion-35
ZENFLuxion-18
ZENFLuxion-14
ZENFLuxion-35
Catheter Type Over-The-WireOTW
Guidewire 0.035”
Catheter Tip Flexible, short and cone-shaped
Balloon Material Nylon
Fold Three / six folds
Coating Paclitaxel coating
Marker 2
Balloon Size Diameter:4.012.0mm; Length:20220mm
Shaft 48F
Usable Length 110cm and 130cm
INDICATIONS
Drug Coated PTA Balloon Catheter
The ZENFLUXION™ Drug-coated PTA Balloon Catheters are indicated for Percutaneous Transluminal Angioplasty PTA of stenosis or occlusion lesions in iliac, femoral or popliteal arteries.
We also have kinds of stroke equipment for sale, if you have needs, please leave us a message.
Basic Information
About Us
TonBridge Medical, headquartered in Zhuhai city, China, is an international medical device company found by a group of returnees with U.S and European professional background. TonBridge offers high quality products worldwide and pioneers the innovations and developments of interventional, Minimally invasive, neurovascular technologies. In 2019, TonBridge was merged with Zylox Medical Tech. to form the group company Zylox-TonBridge. Zylox-TonBridge has been listed on the main board of the HK Stock Market 2190.HK since July, 2020. Today, we have developed more than 45 different types of products and expanded product pipeline of total solutions to ischemic and hemorrhagic strokes.We care people. People safety and satisfaction is our first priority. We are committed to people, life and a better healthcare with conscience and dignity.
